Procyclidine 2.5mg
$19.00 – $64.00

Carbidopa–Levodopa–Entacapone is a prescription medicine used to treat Parkinson’s disease and Parkinson-related movement disorders. It is commonly prescribed by a neurologist (brain and nerve specialist) who manages conditions that affect movement, balance, and coordination.
This medicine contains three active ingredients: Carbidopa, Levodopa, and Entacapone. All three work together in different ways to improve movement control and reduce Parkinson’s symptoms for a longer duration.
Parkinson’s disease is a long-term brain condition. In this disease, the brain produces less dopamine. Dopamine is a natural chemical messenger in the brain that controls smooth and coordinated body movements.
When dopamine levels become low, movement becomes slow and difficult. Patients may develop tremors (shaking), muscle stiffness, slow walking, and poor balance. Tremors mean involuntary shaking of hands, arms, or body.
Carbidopa–Levodopa–Entacapone tablets help improve dopamine activity in the brain and provide longer-lasting symptom relief.
This medicine is important for improving daily activities like walking, speaking, and writing, but it does not cure Parkinson’s disease. It only helps control symptoms and improve quality of life.
Carbidopa–Levodopa–Entacapone works by increasing dopamine levels in the brain and keeping the medicine active for a longer time in the body.
Levodopa is the main active ingredient. It enters the brain and changes into dopamine. Dopamine is needed for smooth, controlled movement and proper communication between brain cells.
In Parkinson’s disease, dopamine-producing brain cells are damaged. Because of this, the brain cannot send proper movement signals to the muscles.
However, Levodopa does not easily reach the brain on its own. A large amount gets broken down in the body before it can work.
Carbidopa helps by preventing this early breakdown of Levodopa in the bloodstream. This allows more Levodopa to reach the brain safely.
Entacapone works in a different way. It blocks an enzyme called COMT (catechol-O-methyl transferase). This enzyme normally breaks down Levodopa in the body.
By blocking COMT, Entacapone slows down the breakdown of Levodopa and keeps it active for a longer time.
When more Levodopa reaches the brain and stays active longer, dopamine levels improve more consistently.
Dopamine acts like a signal transmitter in the brain. It helps send clear and smooth movement signals from the brain to the muscles.
Doctors prescribe Carbidopa–Levodopa–Entacapone mainly for Parkinson’s disease when symptoms become difficult to control with standard therapy.
It is commonly used in:
Parkinson’s disease is a progressive neurological disorder. Progressive means it slowly worsens over time. Neurological means it affects the brain and nervous system.
Motor fluctuations are changes in symptom control during the day. “On” periods mean the medicine is working well. “Off” periods mean symptoms return as the medicine wears off.
A neurologist prescribes this combination when patients need more stable and longer symptom control throughout the day.
This medicine helps improve walking ability, reduce stiffness, and support better daily functioning in long-term Parkinson’s management.
Carbidopa–Levodopa–Entacapone works through a three-step mechanism to improve dopamine levels and extend the effect of Levodopa.
Levodopa enters the brain and is converted into dopamine. Dopamine is essential for smooth movement, coordination, and balance.
In Parkinson’s disease, dopamine levels are low because brain cells that produce dopamine are damaged.
Carbidopa prevents Levodopa from breaking down too early in the body. This increases the amount of Levodopa that reaches the brain.
Entacapone blocks the COMT enzyme, which normally breaks down Levodopa in the body. By blocking this enzyme, Entacapone increases the time Levodopa stays active.
This means more dopamine is produced in the brain and its effect lasts longer.
COMT is a natural enzyme in the body that helps break down certain chemicals and medicines.
By controlling both breakdown and duration, this combination provides more stable dopamine levels throughout the day.
As a result, Carbidopa–Levodopa–Entacapone tablets help reduce stiffness, improve movement control, and decrease “wearing-off” symptoms.
Like all medicines, Carbidopa–Levodopa–Entacapone may cause side effects, especially when the body is adjusting to treatment.
Common side effects include nausea, vomiting, dizziness, headache, and low blood pressure. Low blood pressure may cause lightheadedness or fainting when standing quickly.
Some patients may develop dyskinesia, which means involuntary movements like jerking, twisting, or uncontrolled muscle movements.
Entacapone may cause diarrhea and orange-colored urine. Orange urine is harmless and occurs due to the way the medicine is processed in the body.
Some patients may feel sleepiness, fatigue, or sudden sleep episodes during the day.
Rare side effects include confusion, hallucinations, or mood changes, especially in elderly patients or long-term users.
A neurologist closely monitors treatment and adjusts dosage to maintain balance between symptom control and side effects.
This content is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult an neurologist or qualified healthcare provider before using Carbidopa–Levodopa–Entacapone tablets for Parkinson’s disease or movement disorder management.
| Product name | Carbidopa-Levodopa-Entacapone |
|---|---|
| Category | Parkinson's Disease Medicines |
| Shipping offer | Free shipping on orders of $110.00 or more |